EXHIBIT 99.3
VIA SEDAR
June 4, 2021
Alberta Securities Commission
Autorité des marchés financiers (Québec)
British Columbia Securities Commission
Manitoba Securities Commission
New Brunswick Securities Commission
Service Newfoundland and Labrador
Nova Scotia Securities Commission
Ontario Securities Commission
Prince Edward Island Securities Office
Saskatchewan Financial Services Commission
Re: | Report of Voting Results pursuant to Section 11.3 of National Instrument 51-102 Continuous Disclosure Obligations (« NI 51-102 ») |
Following the Annual and Special Meeting of Shareholders of Liminal BioSciences Inc. (the “Company”) held virtually on June 4, 2021 (the “Meeting”), and in accordance with section 11.3 of NI 51-102, continuous disclosure obligations, we hereby advise you of the matters voted upon at the Meeting and the voting results, the whole as detailed in the Management Information Circular of the Company dated April 19, 2021 (the “Circular”). According to the scrutineers’ report, the shareholders present at the meeting, in person or by proxy, represented 22,136,650 common Shares, or 73.93% of the 29,943,839 common shares outstanding on April 23, 2021, the record date for the Meeting.
Election of Directors of the Company
The six (6) nominees set forth in the Circular were elected as directors of the Company to hold office until the next annual meeting of shareholders or until their successors are elected or appointed.
| | | | | | |
Name of Nominee | | For | | Withheld / Abstain |
| | Votes | % | | Votes | % |
Alek Krstajic | | 20,515,813 | 99.72 | | 57,695 | 0.28 |
Simon Best | | 20,490,765 | 99.60 | | 82,743 | 0.40 |
Gary Bridger | | 20,492,561 | 99.61 | | 80,948 | 0.39 |
Neil A. Klompas | | 20,519,980 | 99.74 | | 53,529 | 0.26 |
Eugene Siklos | | 20,497,078 | 99.63 | | 76,391 | 0.59 |
Timothy Steven Wach | | 20,452,717 | 99.41 | | 120,791 | 0.59 |
| | | |
www.liminalbiosciences.com | info@liminalbiosciences.com | +1.450.781.0115 | Liminal BioSciences inc. 440 Boul. Armand-Frappier, Suite 300 Laval, Québec, H7V4B4, Canada |
Appointment of Auditors
PricewaterhouseCoopers LLP were appointed as auditors of the Company to hold office until the next annual meeting of shareholders, and the board of directors was authorized to fix the auditors’ remuneration.
| | | | |
For | | Withheld / Abstain |
Votes | % | | Votes | % |
21,917,167 | 99.01 | | 218,315 | 0.99 |
Articles of Amendment
The amendment to the articles of the Company to authorize the Company to change the place in Canada where the registered office is situated, from the province of Québec to Ontario, effective as at the discretion of the Board, as described in the Circular, was approved by special resolution.
| | | | |
For | | Against |
Votes | % | | Votes | % |
20,455,729 | 99.43 | | 117,779 | 0.57 |
Liminal BioSciences Inc.
(s) Marie Iskra
Marie Iskra
General Counsel
| | | |
www.liminalbiosciences.com | info@liminalbiosciences.com | +1.450.781.0115 | Liminal BioSciences inc. 440 Boul. Armand-Frappier, Suite 300 Laval, Québec, H7V4B4, Canada |
